Determination of GTI-2040, a novel antisense oligonucleotide, in human plasma by using HPLC combined with solid phase and liquid-liquid extractions

• ZHANG Wenjiang

  Department of Experimental Therapeutics, Ontario Cancer Institute, University Health Network

• LEIGHL Natasha

  Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network

• ZAWISZA Diane

  Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network

• MOORE Malcolm J.

  Department of Experimental Therapeutics, Ontario Cancer Institute, University Health Network

• CHEN Eric X.

  Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network

Journal

• Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 829 (1), 45-49, 2005-12-27

Keywords

• Antisense oligonucleotide
• GTI-2040
• Solid-phase extraction

Details

• CRID: 1572543025232515968
• NII Article ID: 10018965862
• NII Book ID: AA11656178
• ISSN: 15700232
• Text Lang: en
• Data Source:
  • CiNii Articles